Vulpes lagopus strain Blue_001 chromosome 17, ASM1834538v1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Laurasiatheria; Carnivora; Caniformia; Canidae; Vulpes.
Chromosome-level genome assembly of the Arctic fox (Vulpes lagopus) using PacBio sequencing and Hi-C technology
Publication Status: Available-Online prior to print
REFSEQ INFORMATION: The reference sequence is identical to\nCM031311.1.\nAssembly name: ASM1834538v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Hebei Normal University of\nScience and Technology on 2021/05/12. The original whole-genome\nshotgun project has the accession JADWOQ000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Hebei Normal University of Science and\n Technology\nAssembly Method :: WTDBG2 v. 2.5\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 121.0x\nSequencing Technology :: PacBio Sequel; Illumina NovaSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vulpes lagopus Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 8.6\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
potassium calcium-activated channel subfamily M regulatory beta subunit 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium calcium-activated channel subfamily M regulatory beta subunit 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
calcium-activated potassium channel subunit beta-2 isoform X2
calcium-activated potassium channel subunit beta-2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
TBL1X receptor 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
TBL1X receptor 1, transcript variant X12
TBL1X receptor 1, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
F-box-like/WD repeat-containing protein TBL1XR1 isoform X2
F-box-like/WD repeat-containing protein TBL1XR1 isoform X1
F-box-like/WD repeat-containing protein TBL1XR1 isoform X3
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 42% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
N-acetylated alpha-linked acidic dipeptidase like 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
N-acetylated alpha-linked acidic dipeptidase like 2, transcript variant X6
N-acetylated alpha-linked acidic dipeptidase like 2, transcript variant X4
N-acetylated alpha-linked acidic dipeptidase like 2, transcript variant X8
N-acetylated alpha-linked acidic dipeptidase like 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
N-acetylated alpha-linked acidic dipeptidase like 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
N-acetylated alpha-linked acidic dipeptidase like 2, transcript variant X7
N-acetylated alpha-linked acidic dipeptidase like 2, transcript variant X9
N-acetylated alpha-linked acidic dipeptidase like 2, transcript variant X5
N-acetylated alpha-linked acidic dipeptidase like 2, transcript variant X10
inactive N-acetylated-alpha-linked acidic dipeptidase-like protein 2 isoform X1
inactive N-acetylated-alpha-linked acidic dipeptidase-like protein 2 isoform X2
inactive N-acetylated-alpha-linked acidic dipeptidase-like protein 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 13% coverage of the annotated genomic feature by RNAseq alignments
epithelial cell transforming 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
epithelial cell transforming 2, transcript variant X2
epithelial cell transforming 2, transcript variant X6
epithelial cell transforming 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
epithelial cell transforming 2, transcript variant X4
epithelial cell transforming 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tumor necrosis factor ligand superfamily member 10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
growth hormone secretagogue receptor type 1
fibronectin type III domain containing 3B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
fibronectin type III domain-containing protein 3B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
TRAF2 and NCK interacting kinase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
TRAF2 and NCK interacting kinase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
TRAF2 and NCK interacting kinase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
TRAF2 and NCK interacting kinase, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
TRAF2 and NCK interacting kinase, transcript variant X4
TRAF2 and NCK interacting kinase, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
TRAF2 and NCK interacting kinase, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
TRAF2 and NCK-interacting protein kinase isoform X1
TRAF2 and NCK-interacting protein kinase isoform X3
TRAF2 and NCK-interacting protein kinase isoform X2
TRAF2 and NCK-interacting protein kinase isoform X5
TRAF2 and NCK-interacting protein kinase isoform X4
TRAF2 and NCK-interacting protein kinase isoform X6
TRAF2 and NCK-interacting protein kinase isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
bcl-2-binding component 3, isoforms 3/4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 2 member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 2 member 2, transcript variant X3
solute carrier family 2 member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
solute carrier family 2, facilitated glucose transporter member 2 isoform X1
solute carrier family 2, facilitated glucose transporter member 2 isoform X2
eukaryotic translation initiation factor 5A2, transcript variant X1
eukaryotic translation initiation factor 5A2, transcript variant X2
eukaryotic translation initiation factor 5A2, transcript variant X3
eukaryotic translation initiation factor 5A2, transcript variant X5
eukaryotic translation initiation factor 5A2, transcript variant X4
eukaryotic translation initiation factor 5A-2 isoform X3
eukaryotic translation initiation factor 5A-2 isoform X2
eukaryotic translation initiation factor 5A-2 isoform X1
eukaryotic translation initiation factor 5A-2 isoform X4
COORDINATES: nucleotide motif:Rfam:12.0:RF00272
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 18% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
probable cationic amino acid transporter
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
SKI like proto-oncogene, transcript variant X5
SKI like proto-oncogene, transcript variant X1
SKI like proto-oncogene, transcript variant X4
SKI like proto-oncogene, transcript variant X2
SKI like proto-oncogene, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00561
polyhomeotic homolog 3, transcript variant X1
polyhomeotic homolog 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
polyhomeotic homolog 3, transcript variant X4
polyhomeotic homolog 3, transcript variant X3
polyhomeotic homolog 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
G protein-coupled receptor 160, transcript variant X5
G protein-coupled receptor 160, transcript variant X4
G protein-coupled receptor 160, transcript variant X7
G protein-coupled receptor 160, transcript variant X2
G protein-coupled receptor 160, transcript variant X3
G protein-coupled receptor 160, transcript variant X1
G protein-coupled receptor 160, transcript variant X6
probable G-protein coupled receptor 160 isoform X1
G protein-coupled receptor 160, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
probable G-protein coupled receptor 160 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
SEC62 homolog, preprotein translocation factor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
sterile alpha motif domain-containing protein 7
leucine rich repeat containing 31, transcript variant X3
leucine rich repeat containing 31, transcript variant X1
leucine rich repeat containing 31, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 93% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC121477585, transcript variant X2
ATP synthase membrane subunit K, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC121477585, transcript variant X1
uncharacterized LOC121477585, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 17% coverage of the annotated genomic feature by RNAseq alignments
leucine rich repeat containing 31, transcript variant X5
leucine rich repeat containing 31, transcript variant X2
leucine-rich repeat-containing protein 31 isoform X1
leucine rich repeat containing 31, transcript variant X7
leucine rich repeat containing 31, transcript variant X6
leucine-rich repeat-containing protein 31 isoform X2
leucine rich repeats and IQ motif containing 4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: leucine-rich repeat and IQ domain-containing protein 4
leucine rich repeat containing 34, transcript variant X1
leucine-rich repeat-containing protein 34 isoform X1
leucine rich repeat containing 34, transcript variant X2
leucine-rich repeat-containing protein 34 isoform X2
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA valine (anticodon AAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
uncharacterized LOC121477374, transcript variant X1
uncharacterized LOC121477374, transcript variant X2
MDS1 and EVI1 complex locus, transcript variant X7
MDS1 and EVI1 complex locus, transcript variant X3
MDS1 and EVI1 complex locus, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
MDS1 and EVI1 complex locus, transcript variant X4
MDS1 and EVI1 complex locus, transcript variant X2
MDS1 and EVI1 complex locus, transcript variant X11
MDS1 and EVI1 complex locus, transcript variant X5
MDS1 and EVI1 complex locus, transcript variant X12
histone-lysine N-methyltransferase MECOM isoform X1
histone-lysine N-methyltransferase MECOM isoform X4
histone-lysine N-methyltransferase MECOM isoform X10
histone-lysine N-methyltransferase MECOM isoform X2
histone-lysine N-methyltransferase MECOM isoform X5
histone-lysine N-methyltransferase MECOM isoform X11
histone-lysine N-methyltransferase MECOM isoform X3
histone-lysine N-methyltransferase MECOM isoform X7
MDS1 and EVI1 complex locus, transcript variant X8
histone-lysine N-methyltransferase MECOM isoform X8
MDS1 and EVI1 complex locus, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
MDS1 and EVI1 complex locus, transcript variant X6
histone-lysine N-methyltransferase MECOM isoform X6
MDS1 and EVI1 complex locus, transcript variant X10
histone-lysine N-methyltransferase MECOM isoform X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC121477286, transcript variant X23
uncharacterized LOC121477286, transcript variant X20
uncharacterized LOC121477286, transcript variant X22
uncharacterized LOC121477286, transcript variant X13
uncharacterized LOC121477286, transcript variant X19
uncharacterized LOC121477286, transcript variant X21
uncharacterized LOC121477286, transcript variant X10
uncharacterized LOC121477286, transcript variant X14
uncharacterized LOC121477286, transcript variant X18
uncharacterized LOC121477286, transcript variant X7
uncharacterized LOC121477286, transcript variant X12
uncharacterized LOC121477286, transcript variant X25
uncharacterized LOC121477286, transcript variant X3
uncharacterized LOC121477286, transcript variant X8
uncharacterized LOC121477286, transcript variant X24
uncharacterized LOC121477286, transcript variant X17
uncharacterized LOC121477286, transcript variant X4
uncharacterized LOC121477286, transcript variant X6
uncharacterized LOC121477286, transcript variant X2
uncharacterized LOC121477286, transcript variant X5
uncharacterized LOC121477286, transcript variant X16
uncharacterized LOC121477286, transcript variant X9
uncharacterized LOC121477286, transcript variant X1
uncharacterized LOC121477286, transcript variant X15
uncharacterized LOC121477286, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
golgi integral membrane protein 4, transcript variant X2
golgi integral membrane protein 4, transcript variant X4
golgi integral membrane protein 4, transcript variant X1
golgi integral membrane protein 4, transcript variant X3
Golgi integral membrane protein 4 isoform X1
Golgi integral membrane protein 4 isoform X2
Golgi integral membrane protein 4 isoform X3
Golgi integral membrane protein 4 isoform X4
serpin family I member 1, transcript variant X1
serpin family I member 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
serpin family I member 1, transcript variant X6
serpin family I member 1, transcript variant X7
serpin family I member 1, transcript variant X5
serpin family I member 1, transcript variant X3
serpin family I member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
WD repeat domain 49, transcript variant X1
WD repeat domain 49, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
WD repeat-containing protein 49 isoform X1
WD repeat-containing protein 49 isoform X2
zinc finger B-box domain containing, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
zinc finger B-box domain containing, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
zinc finger B-box domain-containing protein 1 isoform X1
zinc finger B-box domain-containing protein 1 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
uncharacterized LOC121477496, transcript variant X1
uncharacterized LOC121477496, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins
SLIT and NTRK like family member 3, transcript variant X1
SLIT and NTRK like family member 3, transcript variant X2
SLIT and NTRK like family member 3, transcript variant X3
SLIT and NTRK like family member 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sucrase-isomaltase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sucrase-isomaltase, transcript variant X3
sucrase-isomaltase, intestinal isoform X1
sucrase-isomaltase, transcript variant X2
sucrase-isomaltase, intestinal isoform X2
anaphase-promoting complex subunit 13-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins
transcription elongation factor A protein-like 8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 28% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 6% coverage of the annotated genomic feature by RNAseq alignments
serine palmitoyltransferase small subunit B, transcript variant X2
serine palmitoyltransferase small subunit B, transcript variant X1
serine palmitoyltransferase small subunit B
NMD3 ribosome export adaptor, transcript variant X2
60S ribosomal export protein NMD3 isoform X2
NMD3 ribosome export adaptor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
60S ribosomal export protein NMD3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 57% coverage of the annotated genomic feature by RNAseq alignments
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X21
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X11
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X28
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X8
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X17
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X37
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X29
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X23
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X10
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X34
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X35
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X4
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X6
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X12
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X24
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X31
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X5
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X3
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X30
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X32
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X14
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X25
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X36
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X20
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X2
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X27
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X13
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X7
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X33
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X18
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X26
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X9
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X16
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group), transcript variant X22
UDP-GalNAc:beta-1, 3-N-acetylgalactosaminyltransferase 1
protein phosphatase, Mg2+/Mn2+ dependent 1L
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
karyopherin subunit alpha 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 40% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC121477311, transcript variant X4
uncharacterized LOC121477311, transcript variant X5
uncharacterized LOC121477311, transcript variant X3
uncharacterized LOC121477311, transcript variant X2
uncharacterized LOC121477311, transcript variant X1
karyopherin subunit alpha 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF01295
tripartite motif containing 59, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tripartite motif containing 59, transcript variant X4
tripartite motif containing 59, transcript variant X2
tripartite motif containing 59, transcript variant X3
tripartite motif containing 59, transcript variant X6
tripartite motif containing 59, transcript variant X7
tripartite motif containing 59, transcript variant X1
structural maintenance of chromosomes protein 4
intraflagellar transport 80, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
intraflagellar transport 80, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
intraflagellar transport 80, transcript variant X3
intraflagellar transport protein 80 homolog isoform X1
intraflagellar transport 80, transcript variant X4
intraflagellar transport protein 80 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized membrane protein C3orf80 homolog
uncharacterized LOC121477517, transcript variant X7
uncharacterized LOC121477517, transcript variant X2
uncharacterized LOC121477517, transcript variant X5
uncharacterized LOC121477517, transcript variant X4
uncharacterized LOC121477517, transcript variant X3
uncharacterized LOC121477517, transcript variant X1
uncharacterized LOC121477517, transcript variant X9
uncharacterized LOC121477517, transcript variant X8
uncharacterized LOC121477517, transcript variant X6
schwannomin-interacting protein 1, transcript variant X1
schwannomin-interacting protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
schwannomin-interacting protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
schwannomin-interacting protein 1, transcript variant X4
schwannomin-interacting protein 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
schwannomin-interacting protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
schwannomin-interacting protein 1 isoform X1
schwannomin-interacting protein 1 isoform X3
schwannomin-interacting protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 45% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 28% coverage of the annotated genomic feature by RNAseq alignments
major facilitator superfamily domain containing 1, transcript variant X2
major facilitator superfamily domain containing 1, transcript variant X1
major facilitator superfamily domain-containing protein 1 isoform X1
major facilitator superfamily domain containing 1, transcript variant X3
major facilitator superfamily domain-containing protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
probable cation-transporting ATPase 13A4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 4% coverage of the annotated genomic feature by RNAseq alignments
probable cation-transporting ATPase 13A5
phospholipase A and acyltransferase 1, transcript variant X2
phospholipase A and acyltransferase 1, transcript variant X3
phospholipase A and acyltransferase 1, transcript variant X7
phospholipase A and acyltransferase 1, transcript variant X1
phospholipase A and acyltransferase 1, transcript variant X5
phospholipase A and acyltransferase 1, transcript variant X6
phospholipase A and acyltransferase 1, transcript variant X4
fibroblast growth factor 12, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
fibroblast growth factor 12, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
fibroblast growth factor 12, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
coiled-coil domain-containing protein 50
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 40% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 41% coverage of the annotated genomic feature by RNAseq alignments
geminin coiled-coil domain-containing protein 1
interleukin 1 receptor accessory protein, transcript variant X2
interleukin 1 receptor accessory protein, transcript variant X1
interleukin 1 receptor accessory protein, transcript variant X3
interleukin-1 receptor accessory protein
chorion-specific transcription factor GCMa-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
tumor protein p63, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tumor protein p63, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tumor protein p63, transcript variant X1
tumor protein p63, transcript variant X3
tumor protein p63, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tumor protein p63, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tumor protein p63, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tumor protein p63 regulated 1, transcript variant X18
tumor protein p63 regulated 1, transcript variant X11
tumor protein p63 regulated 1, transcript variant X13
tumor protein p63 regulated 1, transcript variant X17
tumor protein p63 regulated 1, transcript variant X29
tumor protein p63 regulated 1, transcript variant X28
tumor protein p63 regulated 1, transcript variant X27
tumor protein p63 regulated 1, transcript variant X4
tumor protein p63 regulated 1, transcript variant X23
tumor protein p63 regulated 1, transcript variant X2
tumor protein p63 regulated 1, transcript variant X22
tumor protein p63 regulated 1, transcript variant X26
tumor protein p63 regulated 1, transcript variant X1
tumor protein p63 regulated 1, transcript variant X3
tumor protein p63 regulated 1, transcript variant X24
tumor protein p63 regulated 1, transcript variant X31
tumor protein p63 regulated 1, transcript variant X7
tumor protein p63 regulated 1, transcript variant X16
tumor protein p63 regulated 1, transcript variant X10
tumor protein p63 regulated 1, transcript variant X5
tumor protein p63 regulated 1, transcript variant X30
tumor protein p63 regulated 1, transcript variant X9
tumor protein p63 regulated 1, transcript variant X12
tumor protein p63 regulated 1, transcript variant X20
tumor protein p63 regulated 1, transcript variant X6
tumor protein p63 regulated 1, transcript variant X8
tumor protein p63 regulated 1, transcript variant X19
tumor protein p63 regulated 1, transcript variant X14
tumor protein p63 regulated 1, transcript variant X25
tumor protein p63 regulated 1, transcript variant X21
tumor protein p63 regulated 1, transcript variant X15
tumor protein p63-regulated gene 1 protein isoform X3
tumor protein p63-regulated gene 1 protein isoform X4
tumor protein p63-regulated gene 1 protein isoform X6
tumor protein p63-regulated gene 1 protein isoform X1
tumor protein p63-regulated gene 1 protein isoform X2
tumor protein p63-regulated gene 1 protein isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 83% coverage of the annotated genomic feature by RNAseq alignments
LIM domain containing preferred translocation partner in lipoma, transcript variant X22
LIM domain containing preferred translocation partner in lipoma, transcript variant X1
LIM domain containing preferred translocation partner in lipoma, transcript variant X19
LIM domain containing preferred translocation partner in lipoma, transcript variant X13
LIM domain containing preferred translocation partner in lipoma, transcript variant X12
LIM domain containing preferred translocation partner in lipoma, transcript variant X2
LIM domain containing preferred translocation partner in lipoma, transcript variant X15
LIM domain containing preferred translocation partner in lipoma, transcript variant X9
LIM domain containing preferred translocation partner in lipoma, transcript variant X8
LIM domain containing preferred translocation partner in lipoma, transcript variant X20
LIM domain containing preferred translocation partner in lipoma, transcript variant X16
LIM domain containing preferred translocation partner in lipoma, transcript variant X3
LIM domain containing preferred translocation partner in lipoma, transcript variant X18
LIM domain containing preferred translocation partner in lipoma, transcript variant X5
LIM domain containing preferred translocation partner in lipoma, transcript variant X6
LIM domain containing preferred translocation partner in lipoma, transcript variant X7
LIM domain containing preferred translocation partner in lipoma, transcript variant X4
LIM domain containing preferred translocation partner in lipoma, transcript variant X14
LIM domain containing preferred translocation partner in lipoma, transcript variant X10
LIM domain containing preferred translocation partner in lipoma, transcript variant X21
LIM domain containing preferred translocation partner in lipoma, transcript variant X17
LIM domain containing preferred translocation partner in lipoma, transcript variant X11
LIM domain containing preferred translocation partner in lipoma, transcript variant X23
uncharacterized LOC121477522, transcript variant X2
uncharacterized LOC121477522, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC121477256, transcript variant X2
uncharacterized LOC121477256, transcript variant X1
uncharacterized LOC121477525, transcript variant X4
uncharacterized LOC121477525, transcript variant X3
uncharacterized LOC121477525, transcript variant X2
uncharacterized LOC121477525, transcript variant X1
uncharacterized LOC121477525, transcript variant X5
uncharacterized LOC121477525, transcript variant X7
uncharacterized LOC121477525, transcript variant X8
uncharacterized LOC121477525, transcript variant X6
BCL6 transcription repressor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
BCL6 transcription repressor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
BCL6 transcription repressor, transcript variant X3
receptor transporter protein 4, transcript variant X5
receptor transporter protein 4, transcript variant X2
receptor transporter protein 4, transcript variant X4
receptor transporter protein 4, transcript variant X3
receptor transporter protein 4, transcript variant X1
MBL associated serine protease 1, transcript variant X1
MBL associated serine protease 1, transcript variant X2
MBL associated serine protease 1, transcript variant X4
mannan-binding lectin serine protease 1 isoform X2
mannan-binding lectin serine protease 1 isoform X1
mannan-binding lectin serine protease 1 isoform X4
MBL associated serine protease 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
mannan-binding lectin serine protease 1 isoform X3
ST6 beta-galactoside alpha-2,6-sialyltransferase 1
beta-galactoside alpha-2,6-sialyltransferase 1
adiponectin, C1Q and collagen domain containing, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
adiponectin, C1Q and collagen domain containing, transcript variant X1
adiponectin, C1Q and collagen domain containing, transcript variant X2
adiponectin, C1Q and collagen domain containing, transcript variant X3
translation initiation factor IF-2-like, transcript variant X3
translation initiation factor IF-2-like, transcript variant X1
translation initiation factor IF-2-like, transcript variant X2
translation initiation factor IF-2-like, transcript variant X4
translation initiation factor IF-2-like isoform X1
uncharacterized protein LOC121477292 isoform X2
eukaryotic translation initiation factor 4A2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
eukaryotic initiation factor 4A-II isoform X1
eukaryotic translation initiation factor 4A2, transcript variant X2
eukaryotic initiation factor 4A-II isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00394
COORDINATES: nucleotide motif:Rfam:12.0:RF00092
COORDINATES: nucleotide motif:Rfam:12.0:RF01241
COORDINATES: nucleotide motif:Rfam:12.0:RF01299
TBCC domain containing 1, transcript variant X3
TBCC domain containing 1, transcript variant X2
TBCC domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
TBCC domain-containing protein 1 isoform X1
DnaJ heat shock protein family (Hsp40) member B11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
TBCC domain containing 1, transcript variant X4
TBCC domain containing 1, transcript variant X5
TBCC domain containing 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
TBCC domain containing 1, transcript variant X7
TBCC domain-containing protein 1 isoform X2
diacylglycerol kinase gamma, transcript variant X6
diacylglycerol kinase gamma, transcript variant X7
diacylglycerol kinase gamma, transcript variant X3
diacylglycerol kinase gamma, transcript variant X1
diacylglycerol kinase gamma, transcript variant X4
diacylglycerol kinase gamma, transcript variant X9
diacylglycerol kinase gamma, transcript variant X8
diacylglycerol kinase gamma, transcript variant X5
diacylglycerol kinase gamma, transcript variant X2
diacylglycerol kinase gamma, transcript variant X10
transformer 2 beta homolog, transcript variant X1
transformer 2 beta homolog, transcript variant X2
transformer-2 protein homolog beta isoform X1
transformer-2 protein homolog beta isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 52% coverage of the annotated genomic feature by RNAseq alignments
insulin like growth factor 2 mRNA binding protein 2, transcript variant X1
insulin like growth factor 2 mRNA binding protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
insulin-like growth factor 2 mRNA-binding protein 2 isoform X1
insulin-like growth factor 2 mRNA-binding protein 2 isoform X2
SUMO specific peptidase 2, transcript variant X2
SUMO specific peptidase 2, transcript variant X1
SUMO specific peptidase 2, transcript variant X3
transmembrane protein 41A, transcript variant X1
transmembrane protein 41A, transcript variant X2
mitogen-activated protein kinase kinase kinase 13, transcript variant X2
mitogen-activated protein kinase kinase kinase 13, transcript variant X4
mitogen-activated protein kinase kinase kinase 13, transcript variant X3
mitogen-activated protein kinase kinase kinase 13, transcript variant X7
mitogen-activated protein kinase kinase kinase 13, transcript variant X5
mitogen-activated protein kinase kinase kinase 13, transcript variant X1
mitogen-activated protein kinase kinase kinase 13, transcript variant X6
mitogen-activated protein kinase kinase kinase 13, transcript variant X8
mitogen-activated protein kinase kinase kinase 13, transcript variant X9
mitogen-activated protein kinase kinase kinase 13
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase, transcript variant X1
peroxisomal bifunctional enzyme isoform X1
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase, transcript variant X2
peroxisomal bifunctional enzyme isoform X2
VPS8 subunit of CORVET complex, transcript variant X2
VPS8 subunit of CORVET complex, transcript variant X3
VPS8 subunit of CORVET complex, transcript variant X1
VPS8 subunit of CORVET complex, transcript variant X4
vacuolar protein sorting-associated protein 8 homolog isoform X2
vacuolar protein sorting-associated protein 8 homolog isoform X3
vacuolar protein sorting-associated protein 8 homolog isoform X1
vacuolar protein sorting-associated protein 8 homolog isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
transmembrane epididymal protein 1A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
glyceraldehyde-3-phosphate dehydrogenase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 79% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
RNA polymerase II, I and III subunit H, transcript variant X2
RNA polymerase II, I and III subunit H, transcript variant X1
DNA-directed RNA polymerases I, II, and III subunit RPABC3 isoform X1
DNA-directed RNA polymerases I, II, and III subunit RPABC3 isoform X2
chloride voltage-gated channel 2, transcript variant X2
chloride voltage-gated channel 2, transcript variant X1
family with sequence similarity 131 member A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
family with sequence similarity 131 member A, transcript variant X2
family with sequence similarity 131 member A, transcript variant X4
family with sequence similarity 131 member A, transcript variant X1
eukaryotic translation initiation factor 4 gamma 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: eukaryotic translation initiation factor 4 gamma 1
COORDINATES: nucleotide motif:Rfam:12.0:RF00572
proteasome 26S subunit ubiquitin receptor, non-ATPase 2
26S proteasome non-ATPase regulatory subunit 2
endothelin-converting enzyme 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
endothelin-converting enzyme 2, transcript variant X2
endothelin-converting enzyme 2, transcript variant X3
endothelin-converting enzyme 2, transcript variant X1
endothelin-converting enzyme 2 isoform X5
endothelin-converting enzyme 2 isoform X3
endothelin-converting enzyme 2 isoform X1
endothelin-converting enzyme 2 isoform X2
calcium/calmodulin dependent protein kinase II inhibitor 2, transcript variant X2
calcium/calmodulin dependent protein kinase II inhibitor 2, transcript variant X1
calcium/calmodulin-dependent protein kinase II inhibitor 2
endothelin-converting enzyme 2, transcript variant X4
EEF1A lysine methyltransferase 4 isoform X4
ALG3 alpha-1,3- mannosyltransferase, transcript variant X2
ALG3 alpha-1,3- mannosyltransferase, transcript variant X1
dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase isoform X2
dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase isoform X1
ALG3 alpha-1,3- mannosyltransferase, transcript variant X3
dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase isoform X3
von Willebrand factor A domain containing 5B2, transcript variant X2
von Willebrand factor A domain containing 5B2, transcript variant X1
von Willebrand factor A domain-containing protein 5B2 isoform X2
von Willebrand factor A domain-containing protein 5B2 isoform X1
ATP binding cassette subfamily F member 3
ATP-binding cassette sub-family F member 3
adaptor related protein complex 2 subunit mu 1, transcript variant X2
adaptor related protein complex 2 subunit mu 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
dishevelled segment polarity protein 3, transcript variant X1
segment polarity protein dishevelled homolog DVL-3 isoform X1
dishevelled segment polarity protein 3, transcript variant X2
segment polarity protein dishevelled homolog DVL-3 isoform X2
eukaryotic translation initiation factor 2B subunit epsilon
translation initiation factor eIF-2B subunit epsilon
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 53% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 13% coverage of the annotated genomic feature by RNAseq alignments
ATP binding cassette subfamily C member 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ATP binding cassette subfamily C member 5, transcript variant X5
ATP binding cassette subfamily C member 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
multidrug resistance-associated protein 5 isoform X1
multidrug resistance-associated protein 5 isoform X4
ATP binding cassette subfamily C member 5, transcript variant X4
ATP binding cassette subfamily C member 5, transcript variant X3
multidrug resistance-associated protein 5 isoform X2
multidrug resistance-associated protein 5 isoform X3
presenilins-associated rhomboid-like protein, mitochondrial
MAP6 domain containing 1, transcript variant X3
MAP6 domain containing 1, transcript variant X2
MAP6 domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
kelch like family member 24, transcript variant X1
kelch like family member 24, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
COORDINATES: nucleotide motif:Rfam:12.0:RF01210
MCF.2 cell line derived transforming sequence-like 2
probable guanine nucleotide exchange factor MCF2L2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, transcript variant X6
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, transcript variant X4
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, transcript variant X5
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, transcript variant X1
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, transcript variant X3
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, transcript variant X2
lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase
lysosomal associated membrane protein 3, transcript variant X3
lysosomal associated membrane protein 3, transcript variant X1
lysosome-associated membrane glycoprotein 3 isoform X3
lysosome-associated membrane glycoprotein 3 isoform X1
lysosomal associated membrane protein 3, transcript variant X2
lysosome-associated membrane glycoprotein 3 isoform X2
methylcrotonyl-CoA carboxylase subunit 1, transcript variant X1
methylcrotonyl-CoA carboxylase subunit 1, transcript variant X2
methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial isoform X1
methylcrotonyl-CoA carboxylase subunit 1, transcript variant X3
methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial isoform X2
methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial isoform X3
uncharacterized LOC121477469, transcript variant X1
uncharacterized LOC121477469, transcript variant X2
defective in cullin neddylation 1 domain containing 1, transcript variant X3
defective in cullin neddylation 1 domain containing 1, transcript variant X4
defective in cullin neddylation 1 domain containing 1, transcript variant X1
defective in cullin neddylation 1 domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ATPase phospholipid transporting 11B (putative), transcript variant X4
ATPase phospholipid transporting 11B (putative), transcript variant X3
ATPase phospholipid transporting 11B (putative), transcript variant X2
ATPase phospholipid transporting 11B (putative), transcript variant X1
phospholipid-transporting ATPase IF isoform X3
phospholipid-transporting ATPase IF isoform X1
phospholipid-transporting ATPase IF isoform X2
ATPase phospholipid transporting 11B (putative), transcript variant X5
phospholipid-transporting ATPase IF isoform X4
uncharacterized LOC121477317, transcript variant X5
uncharacterized LOC121477317, transcript variant X1
uncharacterized LOC121477317, transcript variant X3
uncharacterized LOC121477317, transcript variant X2
uncharacterized LOC121477317, transcript variant X4
COORDINATES: nucleotide motif:Rfam:12.0:RF00139
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 129 Proteins, and 57% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC121477241, transcript variant X2
uncharacterized LOC121477241, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 20% coverage of the annotated genomic feature by RNAseq alignments
DnaJ heat shock protein family (Hsp40) member C19
mitochondrial import inner membrane translocase subunit TIM14
FMR1 autosomal homolog 1, transcript variant X4
FMR1 autosomal homolog 1, transcript variant X3
FMR1 autosomal homolog 1, transcript variant X2
FMR1 autosomal homolog 1, transcript variant X1
fragile X mental retardation syndrome-related protein 1 isoform X4
fragile X mental retardation syndrome-related protein 1 isoform X3
fragile X mental retardation syndrome-related protein 1 isoform X2
fragile X mental retardation syndrome-related protein 1 isoform X1
FMR1 autosomal homolog 1, transcript variant X6
FMR1 autosomal homolog 1, transcript variant X5
fragile X mental retardation syndrome-related protein 1 isoform X6
fragile X mental retardation syndrome-related protein 1 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 86% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain-containing protein 39
tetratricopeptide repeat domain 14, transcript variant X1
tetratricopeptide repeat domain 14, transcript variant X2
peroxisomal biogenesis factor 5 like, transcript variant X4
peroxisomal biogenesis factor 5 like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
peroxisomal biogenesis factor 5 like, transcript variant X2
peroxisomal biogenesis factor 5 like, transcript variant X5
peroxisomal biogenesis factor 5 like, transcript variant X3
ubiquitin carboxyl-terminal hydrolase 13
NADH:ubiquinone oxidoreductase subunit B5
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 52% coverage of the annotated genomic feature by RNAseq alignments
mitochondrial ribosomal protein L47, transcript variant X1
mitochondrial ribosomal protein L47, transcript variant X2
39S ribosomal protein L47, mitochondrial isoform X1
39S ribosomal protein L47, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins
G protein subunit beta 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
G protein subunit beta 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
guanine nucleotide-binding protein subunit beta-4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger protein 639, transcript variant X4
zinc finger protein 639, transcript variant X2
zinc finger protein 639, transcript variant X1
zinc finger protein 639, transcript variant X3
zinc finger protein 639, transcript variant X5
potassium calcium-activated channel subfamily M regulatory beta subunit 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 29% coverage of the annotated genomic feature by RNAseq alignments
calcium-activated potassium channel subunit beta-3 isoform X2
potassium calcium-activated channel subfamily M regulatory beta subunit 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 17% coverage of the annotated genomic feature by RNAseq alignments
calcium-activated potassium channel subunit beta-3 isoform X1
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
zinc finger matrin-type 3, transcript variant X1
zinc finger matrin-type 3, transcript variant X2
zinc finger matrin-type protein 3 isoform X1
zinc finger matrin-type protein 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 69% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 501 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
pleckstrin homology and RhoGEF domain containing G4B, transcript variant X2
pleckstrin homology and RhoGEF domain containing G4B, transcript variant X1
pleckstrin homology and RhoGEF domain containing G4B, transcript variant X3
pleckstrin homology domain-containing family G member 4B
leucine-rich repeat-containing protein 14B
coiled-coil domain containing 127, transcript variant X2
coiled-coil domain containing 127, transcript variant X1
coiled-coil domain-containing protein 127
succinate dehydrogenase complex flavoprotein subunit A, transcript variant X1
succinate dehydrogenase complex flavoprotein subunit A, transcript variant X2
succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial isoform X1
succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial isoform X2
programmed cell death 6, transcript variant X2
programmed cell death 6, transcript variant X1
programmed cell death protein 6 isoform X1
programmed cell death protein 6 isoform X2
aryl-hydrocarbon receptor repressor, transcript variant X1
aryl hydrocarbon receptor repressor isoform X1
aryl-hydrocarbon receptor repressor, transcript variant X2
aryl hydrocarbon receptor repressor isoform X2
aryl-hydrocarbon receptor repressor, transcript variant X3
aryl hydrocarbon receptor repressor isoform X3
exocyst complex component 3, transcript variant X2
exocyst complex component 3, transcript variant X1
solute carrier family 9 member A3, transcript variant X1
solute carrier family 9 member A3, transcript variant X3
solute carrier family 9 member A3, transcript variant X2
centrosomal protein 72, transcript variant X1
centrosomal protein of 72 kDa isoform X1
centrosomal protein 72, transcript variant X2
centrosomal protein of 72 kDa isoform X2
tubulin polymerization promoting protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
tubulin polymerization promoting protein, transcript variant X3
tubulin polymerization promoting protein, transcript variant X4
tubulin polymerization promoting protein, transcript variant X2
tubulin polymerization promoting protein, transcript variant X1
tubulin polymerization-promoting protein isoform X2
tubulin polymerization-promoting protein isoform X3
tubulin polymerization-promoting protein isoform X1
palmitoyltransferase ZDHHC11-like, transcript variant X8
palmitoyltransferase ZDHHC11-like, transcript variant X6
palmitoyltransferase ZDHHC11-like, transcript variant X5
palmitoyltransferase ZDHHC11-like, transcript variant X7
palmitoyltransferase ZDHHC11-like, transcript variant X4
palmitoyltransferase ZDHHC11-like, transcript variant X3
palmitoyltransferase ZDHHC11-like, transcript variant X2
palmitoyltransferase ZDHHC11-like, transcript variant X1
palmitoyltransferase ZDHHC11-like isoform X5
palmitoyltransferase ZDHHC11-like isoform X6
palmitoyltransferase ZDHHC11-like isoform X4
palmitoyltransferase ZDHHC11-like isoform X3
palmitoyltransferase ZDHHC11-like isoform X2
palmitoyltransferase ZDHHC11-like isoform X1
bromodomain containing 9, transcript variant X2
bromodomain-containing protein 9 isoform X2
bromodomain containing 9, transcript variant X4
bromodomain containing 9, transcript variant X3
bromodomain containing 9, transcript variant X1
bromodomain-containing protein 9 isoform X4
bromodomain-containing protein 9 isoform X3
bromodomain-containing protein 9 isoform X1
NKD inhibitor of WNT signaling pathway 2, transcript variant X1
protein naked cuticle homolog 2 isoform X1
NKD inhibitor of WNT signaling pathway 2, transcript variant X2
protein naked cuticle homolog 2 isoform X2
solute carrier family 12 member 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 12 member 7, transcript variant X1
solute carrier family 12 member 7, transcript variant X3
solute carrier family 12 member 7, transcript variant X4
solute carrier family 12 member 7 isoform X2
solute carrier family 12 member 7 isoform X1
solute carrier family 12 member 7 isoform X4
solute carrier family 12 member 7 isoform X3
uncharacterized LOC121477244, transcript variant X2
uncharacterized LOC121477244, transcript variant X1
uncharacterized LOC121477244, transcript variant X3
sodium-dependent neutral amino acid transporter B(0)AT1
solute carrier family 6 member 18, transcript variant X1
solute carrier family 6 member 18, transcript variant X2
solute carrier family 6 member 18, transcript variant X3
solute carrier family 6 member 18, transcript variant X4
inactive sodium-dependent neutral amino acid transporter B(0)AT3 isoform X2
inactive sodium-dependent neutral amino acid transporter B(0)AT3 isoform X3
inactive sodium-dependent neutral amino acid transporter B(0)AT3 isoform X1
telomerase reverse transcriptase, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
telomerase reverse transcriptase, transcript variant X2
telomerase reverse transcriptase, transcript variant X4
telomerase reverse transcriptase, transcript variant X3
telomerase reverse transcriptase, transcript variant X1
telomerase reverse transcriptase isoform X3
telomerase reverse transcriptase isoform X5
telomerase reverse transcriptase isoform X2
telomerase reverse transcriptase isoform X4
telomerase reverse transcriptase isoform X1
telomerase reverse transcriptase, transcript variant X6
telomerase reverse transcriptase isoform X6
telomerase reverse transcriptase, transcript variant X7
telomerase reverse transcriptase isoform X7
telomerase reverse transcriptase, transcript variant X14
telomerase reverse transcriptase, transcript variant X12
telomerase reverse transcriptase, transcript variant X13
telomerase reverse transcriptase, transcript variant X9
telomerase reverse transcriptase, transcript variant X11
telomerase reverse transcriptase isoform X9
telomerase reverse transcriptase isoform X10
telomerase reverse transcriptase, transcript variant X10
telomerase reverse transcriptase, transcript variant X8
telomerase reverse transcriptase isoform X8
cleft lip and palate transmembrane protein 1-like protein
solute carrier family 6 member 3, transcript variant X2
solute carrier family 6 member 3, transcript variant X5
solute carrier family 6 member 3, transcript variant X4
solute carrier family 6 member 3, transcript variant X3
solute carrier family 6 member 3, transcript variant X1
sodium-dependent dopamine transporter isoform X4
sodium-dependent dopamine transporter isoform X3
sodium-dependent dopamine transporter isoform X2
sodium-dependent dopamine transporter isoform X1
lysophosphatidylcholine acyltransferase 1
39S ribosomal protein L36, mitochondrial
NADH:ubiquinone oxidoreductase subunit S6
NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial
iroquois homeobox 4, transcript variant X3
iroquois homeobox 4, transcript variant X5
iroquois homeobox 4, transcript variant X2
iroquois homeobox 4, transcript variant X4
iroquois homeobox 4, transcript variant X1
iroquois homeobox 4, transcript variant X6
iroquois-class homeodomain protein IRX-4 isoform X2
iroquois-class homeodomain protein IRX-4 isoform X1
uncharacterized LOC121477587, transcript variant X2
uncharacterized LOC121477587, transcript variant X1
iroquois-class homeodomain protein IRX-2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86% coverage of the annotated genomic feature by RNAseq alignments
iroquois-class homeodomain protein IRX-1
ADAM metallopeptidase with thrombospondin type 1 motif 16
A disintegrin and metalloproteinase with thrombospondin motifs 16
interactor of little elongation complex ELL subunit 1, transcript variant X1
interactor of little elongation complex ELL subunit 1, transcript variant X2
little elongation complex subunit 1 isoform X1
little elongation complex subunit 1 isoform X2
mediator of RNA polymerase II transcription subunit 10
ubiquitin conjugating enzyme E2 Q family like 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
ubiquitin-conjugating enzyme E2Q-like protein 1
RNA cytosine C(5)-methyltransferase NSUN2
terminal nucleotidyltransferase 4A, transcript variant X1
terminal nucleotidyltransferase 4A, transcript variant X2
terminal nucleotidyltransferase 4A, transcript variant X4
terminal nucleotidyltransferase 4A, transcript variant X3
terminal nucleotidyltransferase 4A isoform X1
terminal nucleotidyltransferase 4A isoform X2
terminal nucleotidyltransferase 4A isoform X3
terminal nucleotidyltransferase 4A isoform X4
glucose-induced degradation protein 8 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 73% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: glucose-induced degradation protein 8 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments
basic salivary proline-rich protein 2-like
adenylate cyclase 2, transcript variant X1
adenylate cyclase 2, transcript variant X2
5-methyltetrahydrofolate-homocysteine methyltransferase reductase, transcript variant X3
5-methyltetrahydrofolate-homocysteine methyltransferase reductase, transcript variant X2
FAST kinase domains 3, transcript variant X2
FAST kinase domains 3, transcript variant X1
FAST kinase domain-containing protein 3, mitochondrial isoform X1
FAST kinase domain-containing protein 3, mitochondrial isoform X2
FAST kinase domains 3, transcript variant X3
FAST kinase domain-containing protein 3, mitochondrial isoform X3
5-methyltetrahydrofolate-homocysteine methyltransferase reductase, transcript variant X4
5-methyltetrahydrofolate-homocysteine methyltransferase reductase, transcript variant X1
methionine synthase reductase isoform X1
methionine synthase reductase isoform X2
uncharacterized LOC121477518, transcript variant X1
uncharacterized LOC121477518, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF01156
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
ATP synthase c subunit lysine N-methyltransferase
ATP synthase subunit C lysine N-methyltransferase
carboxymethylenebutenolidase homolog, transcript variant X2
carboxymethylenebutenolidase homolog, transcript variant X1
carboxymethylenebutenolidase homolog isoform X2
carboxymethylenebutenolidase homolog isoform X1
membrane associated ring-CH-type finger 6, transcript variant X2
membrane associated ring-CH-type finger 6, transcript variant X1
E3 ubiquitin-protein ligase MARCHF6 isoform X1
E3 ubiquitin-protein ligase MARCHF6 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
rhophilin associated tail protein 1 like, transcript variant X6
rhophilin associated tail protein 1 like, transcript variant X2
rhophilin associated tail protein 1 like, transcript variant X5
rhophilin associated tail protein 1 like, transcript variant X1
rhophilin associated tail protein 1 like, transcript variant X4
rhophilin associated tail protein 1 like, transcript variant X3
uncharacterized LOC121477500, transcript variant X2
uncharacterized LOC121477500, transcript variant X1
ankyrin repeat domain-containing protein 33B
death associated protein, transcript variant X3
death associated protein, transcript variant X1
death associated protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 34% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC121477271, transcript variant X1
uncharacterized LOC121477271, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
trio Rho guanine nucleotide exchange factor, transcript variant X1
triple functional domain protein isoform X1
trio Rho guanine nucleotide exchange factor, transcript variant X2
triple functional domain protein isoform X2
OTU deubiquitinase with linear linkage specificity like, transcript variant X1
OTU deubiquitinase with linear linkage specificity like, transcript variant X2
inactive ubiquitin thioesterase OTULINL isoform X1
OTU deubiquitinase with linear linkage specificity like, transcript variant X3
inactive ubiquitin thioesterase OTULINL isoform X2
inactive ubiquitin thioesterase OTULINL isoform X3
OTU deubiquitinase with linear linkage specificity, transcript variant X3
OTU deubiquitinase with linear linkage specificity, transcript variant X4
OTU deubiquitinase with linear linkage specificity, transcript variant X1
OTU deubiquitinase with linear linkage specificity, transcript variant X2
ubiquitin thioesterase otulin isoform X1
ubiquitin thioesterase otulin isoform X3
ubiquitin thioesterase otulin isoform X2
ubiquitin thioesterase otulin isoform X4
OTU deubiquitinase with linear linkage specificity, transcript variant X5
ubiquitin thioesterase otulin isoform X5